[Moxonidin in heart failure: new therapeutic principles suppress neurohumoral activation. Supplement to the Congress on "Heart Failure" of the working group on cardiac insufficiency at the European Society for Cardiology. Cologne, May 1997].
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002309:Cardiology; D005060:Europe; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D018377:Neurotransmitter Agents / Q000502:physiology; D012955:Societies, Medical
D000959:Antihypertensive Agents; D007093:Imidazoles; D018377:Neurotransmitter Agents; C043482:moxonidine